Oncology
Decoding the Expressions, Immune Relevance, and Prognostic Values of Ferroptosis Gene TMEM189: A Pan-cancer Analysis
May 2025
Article
Source:
Current Cancer Drug Targets
25,
pp 520
- 537
(2025)
BackgroundTMEM189 is a recently discovered transmembrane protein involved in ether glycerophospholipid synthesis and ferroptosis regulation. However its role in tumors is not well understood.ObjectiveThis study aimed to elucidate the oncogenic effects and prognostic values of TMEM189 in tumors.MethodsWe performed a pan-cancer analysis of TMEM189 using various databases bioinformatics and statistical tools and tissue microarray analysis.ResultsT Read More
Low Expression of SCN4B Predicts Poor Prognosis in Non-small Cell Lung Cancer
May 2025
Article
Source:
Current Cancer Drug Targets
25,
pp 445
- 466
(2025)
BackgroundSodium voltage-gated channel beta subunit 4 (SCN4B) plays a suppressive role in various tumors. However the role of SCN4B in non-small cell lung cancer (NSCLC) is not yet clear. This study aims to investigate the expression of SCN4B in NSCLC patients and its correlation with prognosis.MethodsFirstly the expression of SCN4B in non-small cell lung cancer (NSCLC) was analyzed using The Cancer Genome Atlas (TCGA) dat Read More
Revealing New Prospects: Antipsychotic Drugs Induces Anti-tumor Effects against Gastric Cancer through Inducing Apoptosis
May 2025
Article
Source:
Current Cancer Drug Targets
25,
pp 496
- 508
(2025)
Background and ObjectiveGlobally Gastric Cancer (GC) ranks as the fifth leading cause of cancer-related deaths. GC is a multifaceted malignancy with diverse etiologies; however understanding the shared molecular mechanisms can aid in discovering novel targeted therapies for GC. This study has employed a drug repositioning approach to explore new drug candidates for treating GC.MethodsThe human GC cell lines AGS MKN-45 and KATO-III were treated wi Read More
The Imidazacridine Derivative LPSF/AC-05 Induces Apoptosis, Cell Cycle Arrest, and Topoisomerase II Inhibition in Breast Cancer, Leukemia, and Lymphoma
May 2025
Article
Source:
Current Cancer Drug Targets
25,
pp 431
- 444
(2025)
IntroductionCancer is one of the major causes of morbidity and mortality worldwide. Current treatments for both solid and hematological tumors are associated with severe adverse effects and drug resistance necessitating the development of novel selective antineoplastic drugs.MethodsThe present study describes the antitumor activity of the imidazacridine derivative 5-acridin-9-ylmethylidene-2-thioxoimidazolidin-4-one (LPSF/AC05) in breast cancer Read More
Anti-Resistant Strategies: Icotinib Derivatives as Promising Non-Small Cell Lung Cancer Therapeutics
May 2025
Article
Source:
Current Cancer Drug Targets
25,
pp 483
- 495
(2025)
BackgroundNon-small cell lung cancer (NSCLC) patients often benefit from EGFR inhibitors like gefitinib. However drug resistance remains a significant challenge in treatment. The unique properties of 123-triazole a nitrogen-based compound hold promise as potential solutions due to its versatile structural attributes and diverse biological effects including anticancer properties.Materials and MethodsOur synthesis process involved the huisgen cycloadd Read More
The Pattern of Anemia in Pediatric Solid Tumors Prior to and after Chemotherapy- A Retrospective Cohort Study
May 2025
Article
Source:
Current Cancer Drug Targets
25,
pp 467
- 482
(2025)
BackgroundSolid pediatric tumors refer to cancers that affect children and adolescents and they present unique challenges due to their distinct biological characteristics and their vulnerability to young patients. This study aims to shed light on addressing anemia and the causes of anemia in patients with solid pediatric tumors.Materials and MethodsThis retrospective cohort comprised 200 healthy children as controls and 235 patients with solid tumors. T Read More
GAPVD1 Promotes the Proliferation of Triple-negative Breast Cancer Cells by Regulating the ERK/MAPK Signaling Pathway
May 2025
Article
Source:
Current Cancer Drug Targets
25,
pp 509
- 519
(2025)
BackgroundTriple-Negative Breast Cancer (TNBC) accounts for 15–20% of all breast cancers and approximately 50% of breast cancer deaths. Chemotherapy remains the mainstay of systemic treatment due to the lack of effective therapy targets. Thus more studies are urgently needed to identify new therapeutic targets in TNBC patients.MethodsGAPVD1 expression and prognosis value in breast cancer samples were explored in The Cancer Genome Atlas da Read More
A Review of Anticancer Potential of Conferone, Diversin and Ferutinin; Which One is Stronger for Cancer Therapy?
Apr 2025
Article
Source:
Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents)
25,
pp 378
- 387
(2025)
BackgroundOne of the growing diseases in today's human societies is cancer which has become a major challenge especially in industrialized and developing countries. Cancer treatments are diverse but they usually use surgery chemotherapy and radiotherapy to improve patients. Existing drugs are usually expensive and in some cases are not effective due to drug resistance and side effects. Finding compounds of natural origin can be somewhat effe Read More
Composition and Biological Activity of Flavonoid-containing Fractions of an Extract from Gratiola officinalis L.
Apr 2025
Article
Source:
Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents)
25,
pp 388
- 398
(2025)
IntroductionGratiola officinalis L. (hedge hyssop) a medicinal plant of the Scrophulariaceae family has diuretic purgative and vermifuge properties. It is used as a herbal tea to treat chronic gastroenteritis renal colic jaundice and intestinal worms. Previously we have found that an extract from G. officinalis is nontoxic and has antitumor antioxidant antimicrobial antiinflammatory anticachexic and other properties. Our aims in this study were to separate Read More
Amide Functionalized Novel Pyrrolo-pyrimidine Derivative as Anticancer Agents: Synthesis, Characterization and Molecular Docking Studies
Apr 2025
Article
Source:
Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents)
25,
pp 420
- 432
(2025)
BackgroundThe development of new therapies targeting crucial kinases involved in cancer progression is a promising area of research. Pyrazolo pyrimidine derivatives have emerged as potential candidates for this purpose.ObjectiveThis study aims to synthesize pyrazolo pyrimidine derivatives (5a-5r) evaluate their molecular docking against key kinases and assess their anticancer activity.MethodsThe synthesis involved a multi-step procedure starting wit Read More
Investigation of Apoptotic and Anticancer Effects of 2-substituted Benzothiazoles in Breast Cancer Cell Lines: EGFR Modulation and Mechanistic Insights
Apr 2025
Article
Source:
Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents)
25,
pp 433
- 445
(2025)
Background and ObjectiveBenzothiazole derivatives a class of heterocyclic compounds exhibited diverse biological activities influenced by substituents in the thiazole ring. This study aimed to synthesize these compounds with two functional groups to investigate their potential as anticancer agents particularly against breast cancer. While previous research demonstrated the efficacy of 2-substituted benzothiazoles against glioma and cervical and pancre Read More
Synthesis of Chromene-linked Bis-indole Derivatives as Selective Tumor-associated Carbonic Anhydrase IX Inhibitors
Apr 2025
Article
Source:
Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents)
25,
pp 399
- 410
(2025)
BackgroundSulfonamide derivatives are well-reported hCA IX inhibitors; however they inhibit all types of hCA without any selectivity leading to severe adverse effects. Hence developing a novel non-sulfonamide class of tumor-associated hCA IX inhibitors through non-classical inhibition may provide greater selectivity and better pharmacokinetics.ObjectiveThe objective of this study was to develop non-sulfonamide derivatives as potential human carbonic anhydr Read More
The Mesoionic 1,3,4-thiadiazolium Derivative, MI-D, is a Potential Drug for Treating Glioblastoma by Impairing Mitochondrial Functions Linked to Energy Provision in Glioma Cells
Apr 2025
Article
Source:
Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents)
25,
pp 411
- 419
(2025)
BackgroundMesoionic compound MI-D possesses important biological activities such as anti-inflammatory and antitumoral against melanoma and hepatocarcinoma. Glioblastoma is the most aggressive and common central nervous system tumor in adults. Currently chemotherapies are not entirely effective and the survival of patients diagnosed with glioblastoma is extremely short.ObjectiveIn this study we aimed to evaluate the cytotoxicity o Read More
Capivasertib: First Approved AKT inhibitor for the Treatment of Patients with Breast Cancer
Apr 2025
Article
Source:
Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents)
25,
pp 371
- 377
(2025)
Breast cancer frequently occurs in women. Among the several types of breast cancers almost 50% of breast cancers are caused by one or more gene mutations of the PI3K/mTOR/AKT pathway. Capivasertib the first AKT inhibitor was authorized by the US FDA on November 16 2023. It is used for the treatment of adult patients with hormone receptor-positive human epidermal growth factor receptor 2 negative metastatic breast cancer with at l Read More
Lipid-Based Nanocarriers for Targeted Gene Delivery in Lung Cancer Therapy: Exploring a Novel Therapeutic Paradigm
Apr 2025
Article
Source:
Current Gene Therapy
25,
pp 92
- 112
(2025)
Lung cancer is a significant cause of cancer-related death worldwide. It can be broadly categorised into small-cell lung cancer (SCLC) and Non-small cell lung cancer (NSCLC). Surgical intervention radiation therapy and the administration of chemotherapeutic medications are among the current treatment modalities. However the application of chemotherapy may be limited in more advanced stages of metastasis due to the potential for adverse effe Read More
SLC2A3 is a Potential Factor for Head and Neck Squamous Cancer Development through Tumor Microenvironment Alteration
Apr 2025
Article
Source:
Current Gene Therapy
25,
pp 157
- 177
(2025)
IntroductionTumor immunity has garnered increasing attention in cancer treatment and progression. However there is still a challenge in understanding the mechanisms of specific molecules affecting the clinical prognosis and tumor microenvironment (TME).MethodsHere we applied the ESTIMATE algorithm to calculate the immune and stromal scores in 504 HNSC cases from TCGA. Patients were grouped according to the median value of the immune an Read More
Significance of Ribonucleoside-diphosphate Reductase Subunit M2 in Lung Adenocarcinoma
Apr 2025
Article
Source:
Current Gene Therapy
25,
pp 136
- 156
(2025)
IntroductionThe Ribonucleoside-diphosphate Reductase subunit M2 (RRM2) is known to be overexpressed in various cancers though its specific functional implications remain unclear. This aims to elucidate the role of RRM2 in the progression of Lung Adenocarcinoma (LUAD) by exploring its involvement and potential impact.MethodsRRM2 data were sourced from multiple databases to assess its diagnostic and prognostic significance in LUAD. We evalu Read More
Single-cell and Bulk Transcriptomic Analyses Reveal a Stemness and Circadian Rhythm Disturbance-related Signature Predicting Clinical Outcome and Immunotherapy Response in Hepatocellular Carcinoma
Apr 2025
Article
Source:
Current Gene Therapy
25,
pp 178
- 193
(2025)
AimsInvestigating the impact of stemness-related circadian rhythm disruption (SCRD) on hepatocellular carcinoma (HCC) prognosis and its potential as a predictor for immunotherapy response.BackgroundCircadian disruption has been linked to tumor progression through its effect on the stemness of cancer cells.ObjectiveDevelop a novel signature for SCRD to accurately predict clinical outcomes and immune therapy response in patients with HCC.Met Read More
Theranostic Potential of Bacteriophages against Oral Squamous Cell Carcinoma
Apr 2025
Article
Source:
Current Gene Therapy
25,
pp 89
- 91
(2025)
Oral Squamous Cell Carcinoma (OSCC) is a widespread and challenging disease that accounts for 94% of cancers of the oral cavity worldwide. Bacteriophages (phages) have shown promise as a potential theranostic agent for the treatment of OSCC. It may offer advantages in overcoming the challenges of conventional methods. Modern high-throughput pyrosequencing techniques confirm the presence of specific bacterial strains associ Read More
Role of Non-coding RNAs on the Radiotherapy Sensitivity and Resistance in Cancer Cells
Apr 2025
Article
Source:
Current Gene Therapy
25,
pp 113
- 135
(2025)
Radiotherapy (RT) is an integral part of treatment management in cancer patients. However one of the limitations of this treatment method is the resistance of cancer cells to radiotherapy. These restrictions necessitate the introduction of modalities for the radiosensitization of cancer cells. It has been shown that Noncoding RNAs (ncRNAs) along with modifiers can act as radiosensitivity and radioresistant regulators in a variety of cancers by affecting double Read More
No more items...